Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sonoma Pharmaceuticals (SNOA) Gross Margin (2020 - 2022)

Sonoma Pharmaceuticals (SNOA) has 3 years of Gross Margin data on record, last reported at 31.29% in Q4 2012.

  • For Q4 2012, Gross Margin fell 9767.0% year-over-year to 31.29%; the TTM value through Dec 2012 reached 152.41%, down 273200.0%, while the annual FY2012 figure was 68.38%, 59337.0% down from the prior year.
  • Gross Margin reached 31.29% in Q4 2012 per SNOA's latest filing, down from 67.21% in the prior quarter.
  • Across five years, Gross Margin topped out at 847.39% in Q2 2011 and bottomed at 31.56% in Q1 2011.
  • Average Gross Margin over 3 years is 166.4%, with a median of 66.38% recorded in 2011.
  • Peak YoY movement for Gross Margin: surged 21314bps in 2011, then tumbled -77181bps in 2012.
  • A 3-year view of Gross Margin shows it stood at 49.68% in 2010, then skyrocketed by 34bps to 66.38% in 2011, then crashed by -147bps to 31.29% in 2012.
  • Per Business Quant database, its latest 3 readings for Gross Margin were 31.29% in Q4 2012, 67.21% in Q3 2012, and 75.58% in Q2 2012.